» Articles » PMID: 24142697

Cysteine Racemization on IgG Heavy and Light Chains

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Oct 22
PMID 24142697
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Under basic pH conditions, the heavy chain 220-light chain 214 (H220-L214) disulfide bond, found in the flexible hinge region of an IgG1, can convert to a thioether. Similar conditions also result in racemization of the H220 cysteine. Here, we report that racemization occurs on both H220 and L214 on an IgG1 with a λ light chain (IgG1λ) but almost entirely on H220 of an IgGl with a κ light chain (IgG1κ) under similar conditions. Likewise, racemization was detected at significant levels on H220 and L214 on endogenous human IgG1λ but only at the H220 position on IgG1κ. Low but measurable levels of D-cysteines were found on IgG2 cysteines in the hinge region, both with monoclonal antibodies incubated under basic pH conditions and on antibodies isolated from human serum. A simplified reaction mechanism involving reversible β-elimination on the cysteine is presented that accounts for both base-catalyzed racemization and thioether formation at the hinge disulfide.

Citing Articles

Stability of Protein Pharmaceuticals: Recent Advances.

Manning M, Holcomb R, Payne R, Stillahn J, Connolly B, Katayama D Pharm Res. 2024; 41(7):1301-1367.

PMID: 38937372 DOI: 10.1007/s11095-024-03726-x.


Micro-Heterogeneity of Antibody Molecules.

Mimura Y, Saldova R, Mimura-Kimura Y, Rudd P, Jefferis R Exp Suppl. 2021; 112:1-26.

PMID: 34687006 DOI: 10.1007/978-3-030-76912-3_1.


Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum.

Ayalew L, DSouza A, Chen Y, Kim M MAbs. 2020; 12(1):1854923.

PMID: 33317401 PMC: 7755172. DOI: 10.1080/19420862.2020.1854923.


Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies.

Beck A, Liu H Antibodies (Basel). 2019; 8(1).

PMID: 31544824 PMC: 6640695. DOI: 10.3390/antib8010018.


Structure, heterogeneity and developability assessment of therapeutic antibodies.

Xu Y, Wang D, Mason B, Rossomando T, Li N, Liu D MAbs. 2018; 11(2):239-264.

PMID: 30543482 PMC: 6380400. DOI: 10.1080/19420862.2018.1553476.


References
1.
Hutterer K, Hong R, Lull J, Zhao X, Wang T, Pei R . Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects. MAbs. 2013; 5(4):608-13. PMC: 3906314. DOI: 10.4161/mabs.24725. View

2.
Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen M . Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem. 2008; 283(23):16194-205. PMC: 3259661. DOI: 10.1074/jbc.M709987200. View

3.
Yan B, Yates Z, Balland A, Kleemann G . Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage. J Biol Chem. 2009; 284(51):35390-402. PMC: 2790968. DOI: 10.1074/jbc.M109.064147. View

4.
Bessems G, Rennen H, Hoenders H . Lanthionine, a protein cross-link in cataractous human lenses. Exp Eye Res. 1987; 44(5):691-5. DOI: 10.1016/s0014-4835(87)80139-2. View

5.
Liu H, May K . Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. MAbs. 2012; 4(1):17-23. PMC: 3338938. DOI: 10.4161/mabs.4.1.18347. View